WebFeb 20, 2024 · A low platelet count is a common complication of chronic liver disease. It can happen for many reasons, depending on the cause of your liver disease. ... cyclophosphamide (Cytoxan) azathioprine ... WebSep 7, 2024 · Low Platelet Count (Thrombocytopenia) Platelets help your blood clot, so when the count is low you are at a higher risk of bleeding. Let your oncology care team …
Thrombocytopenia - Harvard Health
WebFeb 23, 2024 · Cytoxan (cyclophosphamide) is an orally administered prescription medication pill used to treat a variety of cancers in adults and children, such as … WebOne of the most common causes of low platelets is a condition called immune thrombocytopenia (ITP). You may hear it called by its old name, idiopathic … ttkbootstrap scrolledtext
JPM Free Full-Text Feasibility and Toxicity of Interval …
WebHair thinning/loss. Low white blood cell count. Hemorrhagic cystitis. Infertility. To control nausea associated with Cytoxan therapy, your doctor will probably give you either … In general, much lower doses of cyclophosphamide are used to treat vasculitis than are used to treat cancer. However, the doses of cyclophosphamide used to treat vasculitis are still high enough to cause a significant number of side–effects, and the drug must be used with great caution. See more Cyclophosphamide increases the risk of “opportunistic” infections, i.e. infections that a person’s intact immune system would normally be … See more The bone marrow is the organ of the body that makes red blood cells (which carry oxygen), white blood cells (which fight infection), and platelets (which help the blood clot). Nearly all patients treated with cyclophosphamide … See more In addition to cancer, cyclophosphamide may cause a variable amount of bleeding from the bladder, a complication known as “hemorrhagic cystitis”. This bleeding may range from a few red blood cells in the urine (invisible to the … See more Many of the side–effects of cyclophosphamide are most likely to occur while the patient is taking the medication. With those side–effects, the risk of their occurrence diminishes greatly after discontinuation of the … See more WebApr 14, 2024 · Twelve Asian patients with sarcoma received interval-compressed (ic-) chemotherapy scheduled every 14 days with a regimen of vincristine (2 mg/m2), doxorubicin (75 mg/m2), and cyclophosphamide (1200–2200 mg/m2) (VDC) alternating with a regimen of ifosfamide (9000 mg/m2) and etoposide (500 mg/m2) (IE), with filgrastim … ttk bootstrap themes